Domestic and donor financing for tuberculosis care and control in low-income and middle-income countries: an analysis of trends, 2002-11, and requirements to meet 2015 targets
- PMID: 25104145
- DOI: 10.1016/S2214-109X(13)70032-9
Domestic and donor financing for tuberculosis care and control in low-income and middle-income countries: an analysis of trends, 2002-11, and requirements to meet 2015 targets
Abstract
Background: Progress in tuberculosis control worldwide, including achievement of 2015 global targets, requires adequate financing sustained for many years. WHO began yearly monitoring of tuberculosis funding in 2002. We used data reported to WHO to analyse tuberculosis funding from governments and international donors (in real terms, constant 2011 US$) and associated progress in tuberculosis control in low-income and middle-income countries between 2002 and 2011. We then assessed funding needed to 2015 and how this funding could be mobilised.
Methods: We included low-income and middle-income countries that reported data about financing for tuberculosis to WHO and had at least three observations between 2002 and 2011. When data were missing for specific country-year combinations, we imputed the missing data. We aggregated country-specific results for eight country groups defined according to income level, political and economic profile, geography, and tuberculosis burden. We compared absolute changes in total funding with those in the total number of patients successfully treated and did cross-country comparisons of cost per successfully treated patient relative to gross domestic product. We estimated funding needs for tuberculosis care and control for all low-income and middle-income countries to 2015, and compared these needs with domestic funding that could be mobilised.
Findings: Total funding grew from $1·7 billion in 2002 to $4·4 billion in 2011. It was mostly spent on diagnosis and treatment of drug-susceptible tuberculosis. 43 million patients were successfully treated, usually for $100-500 per person in countries with high burdens of tuberculosis. Domestic funding rose from $1·5 billion to $3·9 billion per year, mostly in Brazil, Russia, India, China, and South Africa (BRICS), which collectively account for 45% of global cases, where national contributions accounted for more than 95% of yearly funding. Donor funding increased from $0·2 billion in 2002 to $0·5 billion in 2011, and accounted for a mean of 39% of funding in the 17 countries with the highest burdens (excluding BRICS) and a mean of 67% in low-income countries by 2011. BRICS and upper middle-income countries could mobilise almost all of their funding needs to 2015 from domestic sources. A full response to the tuberculosis epidemic to 2015, including investments to tackle multidrug-resistant tuberculosis, will require international donor funding of $1·6-2·3 billion each year.
Interpretation: Funding for tuberculosis control increased substantially between 2002 and 2011, resulting in impressive and cost-effective gains. The increasing self-sufficiency of many countries, including BRICS, which account for almost half the world's tuberculosis cases, is a success story for control of tuberculosis. Nonetheless, international donor funding remains crucial in many countries and more is needed to achieve 2015 targets.
Funding: None.
Copyright © 2013 World Health Organization; licensee Elsevier. Published by .. All rights reserved.
Comment in
-
Financing tuberculosis control: promising trends and remaining challenges.Lancet Glob Health. 2013 Aug;1(2):e62-e63. doi: 10.1016/S2214-109X(13)70044-5. Epub 2013 Jul 24. Lancet Glob Health. 2013. PMID: 25104150 No abstract available.
-
The need for more investment in tuberculosis research.Lancet Glob Health. 2013 Oct;1(4):e186. doi: 10.1016/S2214-109X(13)70087-1. Epub 2013 Sep 24. Lancet Glob Health. 2013. PMID: 25104344 No abstract available.
Similar articles
-
Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995-2050.Lancet. 2019 Jun 1;393(10187):2233-2260. doi: 10.1016/S0140-6736(19)30841-4. Epub 2019 Apr 25. Lancet. 2019. PMID: 31030984 Free PMC article.
-
Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study.Lancet HIV. 2019 Jun;6(6):e382-e395. doi: 10.1016/S2352-3018(19)30038-4. Epub 2019 Apr 26. Lancet HIV. 2019. PMID: 31036482 Free PMC article.
-
Financing tuberculosis control: promising trends and remaining challenges.Lancet Glob Health. 2013 Aug;1(2):e62-e63. doi: 10.1016/S2214-109X(13)70044-5. Epub 2013 Jul 24. Lancet Glob Health. 2013. PMID: 25104150 No abstract available.
-
Tuberculosis.In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.
-
Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050.Lancet. 2021 Oct 9;398(10308):1317-1343. doi: 10.1016/S0140-6736(21)01258-7. Epub 2021 Sep 22. Lancet. 2021. PMID: 34562388 Free PMC article. Review.
Cited by 20 articles
-
An integrated hospital-district performance evaluation for communicable diseases in low-and middle-income countries: Evidence from a pilot in three sub-Saharan countries.PLoS One. 2022 Mar 31;17(3):e0266225. doi: 10.1371/journal.pone.0266225. eCollection 2022. PLoS One. 2022. PMID: 35358254 Free PMC article.
-
Cost of TB services in healthcare facilities in Kenya (No 3).Int J Tuberc Lung Dis. 2021 Dec 1;25(12):1028-1034. doi: 10.5588/ijtld.21.0129. Int J Tuberc Lung Dis. 2021. PMID: 34886934 Free PMC article.
-
Health priority-setting for official development assistance in low-income and middle-income countries: a Best Fit Framework Synthesis study with primary data from Ethiopia, Nigeria and Tanzania.BMC Public Health. 2021 Nov 21;21(1):2138. doi: 10.1186/s12889-021-12205-6. BMC Public Health. 2021. PMID: 34801001 Free PMC article.
-
Drug-Resistant Tuberculosis Among Children: A Systematic Review and Meta-Analysis.Front Public Health. 2021 Aug 18;9:721817. doi: 10.3389/fpubh.2021.721817. eCollection 2021. Front Public Health. 2021. PMID: 34490197 Free PMC article.
-
Current Status and the Epidemiology of Malaria in the Middle East Region and Beyond.Microorganisms. 2021 Feb 9;9(2):338. doi: 10.3390/microorganisms9020338. Microorganisms. 2021. PMID: 33572053 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
